Mentioned:Joby AviationResonant Sciences
Joby Aviation is acquiring EBITDA-positive defense technology company Resonant Sciences while expanding its autonomy-focused U.S. Air Force contracts to approximately $37 million. The dual announcement reflects the company's shift toward defense applications and DoD confidence in its autonomous aircraft platform.
What's happening
- Joby planned the acquisition of Resonant Sciences, which has $100 million-plus in trailing twelve-month revenue and operates as EBITDA-positive with established defense programs and classified capabilities.
- Joby's autonomy-focused Air Force contracts expanded to approximately $37 million, announced November 4, 2026.
- Joby's J208 autonomous aircraft completed the first fully autonomous flight of a civilian aircraft across the United States in 2026.
- Joby raised its full-year 2026 revenue outlook 15 percent to a range of $135 million to $140 million, incorporating defense expansion and manufacturing growth.
Why it matters
- Resonant Sciences acquisition adds scaled manufacturing operations and established defense programs, expanding Joby's addressable market beyond commercial air taxi services into classified DoD applications.
- Air Force contract expansion to $37 million indicates sustained government demand for autonomous aircraft capabilities and validates Joby's autonomy technology for defense use cases.
- Integration of Resonant Sciences' $100 million-plus revenue base accelerates Joby's path to profitability and diversifies revenue away from Blade passenger operations, which carried $55 million in Q3 2026.
- Joby's autonomy demonstration and Air Force traction position the company as a prime contractor in emerging DoD autonomous systems procurement, a high-growth defense industrial segment.
Going deeper
- Resonant Sciences brings classified capabilities to Joby, suggesting the acquisition targets government-only applications requiring security clearances and restricted manufacturing.
- Joby holds $2.2 billion in cash, cash equivalents and short-term investments as of September 30, 2026, providing runway for the acquisition and anticipated second-half 2026 cash burn of $385 million to $415 million.
- Joby advanced toward FAA type certification in Q3 2026 by completing 'for credit' testing in the fifth and final stage, positioning commercial operations near regulatory approval.
Financial impact
- Joby raised full-year 2026 revenue guidance 15 percent to $135 million to $140 million in November 2026, incorporating defense contracts and Blade operations but not yet reflecting Resonant Sciences contribution.
- Acquisition terms undisclosed; purchase price funding and goodwill treatment unknown pending deal close documentation.
- Air Force contract value of $37 million will recognize as revenue over the contract period of performance, timing not disclosed; contract structure (ceiling versus obligated funds) not specified.
- Resonant Sciences' $100 million-plus trailing revenue will add to Joby consolidated revenue upon acquisition close; integration accretion or margin impact not disclosed.
The fine print
- Resonant Sciences acquisition is planned but not yet closed; regulatory approvals, including Committee on Foreign Investment in the United States review if applicable, timing not disclosed.
- Air Force contract value of approximately $37 million does not distinguish between ceiling value and obligated funds or specify option years.
- Purchase price, deal structure and earnout terms for Resonant Sciences acquisition undisclosed.
- Forward-looking statements in earnings release subject to risks including regulatory delays, manufacturing execution and competitive pressure in autonomous systems markets.
Source: jobyaviation.com · Nov 4, 2026 · Drafted with Claude, reviewed by Industrial Base Alpha.
